122 related articles for article (PubMed ID: 9249219)
1. Safety and efficacy of Intralipid emulsions of amphotericin B.
Herbrecht R; Letscher V
J Antimicrob Chemother; 1997 Jul; 40(1):137-9. PubMed ID: 9249219
[No Abstract] [Full Text] [Related]
2. Safety and efficacy of Intralipid emulsions of amphotericin B.
Sievers TM; Kubak BM; Wong-Beringer A
J Antimicrob Chemother; 1996 Sep; 38(3):333-47. PubMed ID: 8889711
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of high-dose infusions of a preformed amphotericin B fat emulsion for treatment of Indian visceral leishmaniasis.
Sundar S; Singh A; Agarwal D; Rai M; Agrawal N; Chakravarty J
Am J Trop Med Hyg; 2009 May; 80(5):700-3. PubMed ID: 19407109
[TBL] [Abstract][Full Text] [Related]
4. Safety and toxicity of amphotericin B in glucose 5% or intralipid 20% in neutropenic patients with pneumonia or fever of unknown origin: randomised study.
Schöffski P; Freund M; Wunder R; Petersen D; Köhne CH; Hecker H; Schubert U; Ganser A
BMJ; 1998 Aug; 317(7155):379-84. PubMed ID: 9694753
[TBL] [Abstract][Full Text] [Related]
5. Amphotericin B in fat emulsion.
Kintzel PE
Am J Health Syst Pharm; 1996 Nov; 53(22):2701. PubMed ID: 8931810
[No Abstract] [Full Text] [Related]
6. Intralipid in prophylaxis of amphotericin B nephrotoxicity.
Vita E; Schroeder DJ
Ann Pharmacother; 1994 Oct; 28(10):1182-3. PubMed ID: 7841575
[No Abstract] [Full Text] [Related]
7. [Use of amphotericin B in lipid emulsions: does it prevent its toxicity in critically ill patients?].
Hernández G; Altermatt F; Bernucci F; Acuña D; Apablaza F; Valenzuela F; Lefio A; Pérez C; Bugedo G; Castillo L
Rev Med Chil; 2000 Oct; 128(10):1101-7. PubMed ID: 11349508
[TBL] [Abstract][Full Text] [Related]
8. Randomized comparison of amphotericin B deoxycholate dissolved in dextrose or Intralipid for the treatment of AIDS-associated cryptococcal meningitis.
Joly V; Aubry P; Ndayiragide A; Carrière I; Kawa E; Mlika-Cabanne N; Aboulker JP; Coulaud JP; Larouze B; Yeni P
Clin Infect Dis; 1996 Sep; 23(3):556-62. PubMed ID: 8879780
[TBL] [Abstract][Full Text] [Related]
9. [Amphotericin B-intralipid 20% combination. In vivo evaluation of its tolerability].
Débat Zoguéreh D; Poignard P; Sorriaux A; Brouqui P
Ann Med Interne (Paris); 1997; 148(1):100-2. PubMed ID: 9137701
[No Abstract] [Full Text] [Related]
10. Amphotericin B--fat emulsion in treatment of visceral leishmaniasis--a cost effective substitute for liposomal amphotericin B.
Singh GP; Saxena RK; Priyadarshy V
J Indian Med Assoc; 2010 Jan; 108(1):27-8. PubMed ID: 20839576
[TBL] [Abstract][Full Text] [Related]
11. Comparison of glucose versus fat emulsion in the preparation of amphotericin B for use in kala-azar.
Thakur CP
Trans R Soc Trop Med Hyg; 1994; 88(6):698-9. PubMed ID: 7886778
[No Abstract] [Full Text] [Related]
12. Acute renal failure with amphotericin B in lipid emulsion.
Gales MA; Gales BJ; Alford KM
Ann Pharmacother; 1996 Sep; 30(9):1036. PubMed ID: 8876871
[No Abstract] [Full Text] [Related]
13. Administration of lipid-emulsion versus conventional amphotericin B in patients with neutropenia.
Pascual B; Ayestaran A; Montoro JB; Oliveras J; Estibalez A; Julia A; Lopez A
Ann Pharmacother; 1995 Dec; 29(12):1197-201. PubMed ID: 8672820
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of visceral leishmaniasis with high-dose amphotericin B diluted in fat emulsion: a case report.
Herbrecht R; Sosa C; Himy R; Villard O
Trans R Soc Trop Med Hyg; 1996; 90(3):322-3. PubMed ID: 8758094
[No Abstract] [Full Text] [Related]
15. Amphotericin B toxicity reduced by administration in fat emulsion.
Anderson RP; Clark DA
Ann Pharmacother; 1995 May; 29(5):496-500. PubMed ID: 7655134
[TBL] [Abstract][Full Text] [Related]
16. ABLE: a new and improved amphotericin B for visceral leishmaniasis?
Berman J
Am J Trop Med Hyg; 2009 May; 80(5):689-90. PubMed ID: 19407106
[No Abstract] [Full Text] [Related]
17. Use of intralipid as a vehicle for amphotericin B in the treatment of cryptococcal meningitis in a renal transplant recipient.
Nicol AJ; Cassidy MJ; Michalowsky K; Kahn D
Nephron; 1996; 73(2):312-3. PubMed ID: 8773363
[No Abstract] [Full Text] [Related]
18. Efficacy of Intralipid infusion in reducing amphotericin-B-associated nephrotoxicity in head and neck invasive fungal infection: A randomized, controlled trial.
Hasibi M; Jafari S; Manshadi SA; Asadollahi M; Salehi M; Zarch VV; Kouhi A
Ear Nose Throat J; 2017 Feb; 96(2):E18-E22. PubMed ID: 28231371
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerance of an amphotericin B lipid (Intralipid) emulsion in the treatment of candidaemia in neutropenic patients.
Caillot D; Casasnovas O; Solary E; Chavanet P; Bonnotte B; Reny G; Entezam F; Lopez J; Bonnin A; Guy H
J Antimicrob Chemother; 1993 Jan; 31(1):161-9. PubMed ID: 8444659
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of amphotericin B lipid-based formulations-A systematic review and meta-analysis.
Steimbach LM; Tonin FS; Virtuoso S; Borba HH; Sanches AC; Wiens A; Fernandez-Llimós F; Pontarolo R
Mycoses; 2017 Mar; 60(3):146-154. PubMed ID: 27878878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
